Depyrogenated Sterile Empty Vials Market Size

Depyrogenated Sterile Empty Vials Market size exceeded USD 0.8 Billion in 2019 and is expected to achieve over 7.6% CAGR up to 2026. Increasing demand in various research laboratories and clinical settings will drive industry growth during the forthcoming years.

Depyrogenation process can be defined as the reduction of pyrogens, including bacterial endotoxins, either by inactivation or removal. Depyrogenation is critical in preparing packaging solutions for injectable drug products. Pharmaceutical packaging components such as vials, ampoules and stoppers require specific depyrogenation procedures based on the component’s material. The commonly used depyrogenation techniques include dry heat, moist heat, rinsing and ultrafiltration.

Packaging of pharmaceutical products is a broad multi-faceted and encompassing task. It differs substantially from other packaging and requires the application of large amount of scientific as well as engineering expertise to deliver a product. It focuses on information and knowledge from a wide range of scientific disciplines, including chemistry, material science, physical testing and engineering, among others.

Focus of industry players on introduction of novel and advanced vials has led to development of various depyrogenated sterile empty vials over the recent years. Market players such as Gerresheimer, Stevanato, SGD Pharma, Thermo Fisher Scientific and others are focusing their efforts on R&D activities for development of technologically advanced depyrogenated sterile empty vial manufacturing platform. Increasing demand for depyrogenated sterile empty vials in various research laboratories and clinical settings will further drive industry growth during the forthcoming years.